StockNews.com Begins Coverage on Enzo Biochem (NYSE:ENZ)

StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a report released on Friday. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Price Performance

NYSE:ENZ opened at $0.33 on Friday. Enzo Biochem has a 1 year low of $0.25 and a 1 year high of $1.28. The business has a fifty day simple moving average of $0.39 and a two-hundred day simple moving average of $0.69.

Enzo Biochem (NYSE:ENZ) last announced its quarterly earnings data on Monday, March 17th. The medical research company reported ($0.02) earnings per share for the quarter. The firm had revenue of $7.33 million during the quarter. Enzo Biochem had a negative return on equity of 7.96% and a negative net margin of 75.34%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Mink Brook Asset Management LLC purchased a new stake in shares of Enzo Biochem during the fourth quarter worth $577,000. Wittenberg Investment Management Inc. raised its stake in shares of Enzo Biochem by 60.1% during the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after purchasing an additional 70,400 shares during the period. Virtu Financial LLC purchased a new stake in Enzo Biochem during the 4th quarter worth about $35,000. Lepercq Multi Asset Fund bought a new position in Enzo Biochem in the 4th quarter worth about $88,000. Finally, Geode Capital Management LLC boosted its stake in Enzo Biochem by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares during the period. 36.90% of the stock is owned by institutional investors.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.